| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Naltrexone | FAERS: 3 | US FAERS | |
| 2 | Methylprednisolone | FAERS: 2 | US FAERS | |
| 3 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 4 | Baclofen | FAERS: 1 | US FAERS | |
| 5 | Clozapine | FAERS: 1 | US FAERS | |
| 6 | Dasatinib | FAERS: 1 | US FAERS | |
| 7 | Morphine | FAERS: 1 | US FAERS | |
| 8 | Triamcinolone | FAERS: 1 | US FAERS | |
| 9 | Vigabatrin | FAERS: 1 | US FAERS | |
| 10 | Vosevi | FAERS: 1 | US FAERS | |
| 11 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 12 | valbenazine | FAERS: 1 | US FAERS | |
| 13 | Mirtazapine | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.